Effectiveness of Four Mini-screws Supported Hyrax for Maxillary Expansion in Early Adulthood
Launched by CAIRO UNIVERSITY · Aug 30, 2023
Trial Information
Current as of June 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a dental treatment called the Four Mini-screws Supported Hyrax, which is used to help expand the upper jaw in adults who have a condition known as transverse maxillary deficiency. This condition often leads to issues like a cross-bite, where the upper teeth do not align properly with the lower teeth. The goal of the study is to see how effective this treatment is compared to not receiving any treatment at all.
To participate in this trial, individuals need to be between the ages of 18 and 30 and have specific dental issues, such as a cross-bite and a narrow upper jaw. Participants should have good oral hygiene and no other serious dental or facial conditions. Throughout the trial, participants can expect to receive the Hyrax treatment and be monitored for how well it works. It's important to note that the study is currently active but not recruiting new participants at this time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unilateral or bilateral Dental posterior cross-bite
- • Skeletal Maxillary constriction
- • Male and female patients.
- • Chronological age (18-30 years).
- • Mid-palatal suture maturation (Grade C,D ) according to F Angileri classification
- • Good oral hygiene.
- • No craniofacial anomalies or syndromes
- Exclusion Criteria:
- • Scissor-bite
- • Orthodontically-treated
- • functional cross bite due to premature occlusal contact
- • patients with a syndrome
- • cleft patients
- • Mid-palatal suture maturation(Grade A.B,E) according to F Angileri classification
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Giza, Egypt
Patients applied
Trial Officials
Elzubair Osman
Principal Investigator
Master Degree student ,Faculty of Dentistry, Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported